Filing Flows › Cirtran (CIRX) › Q1 2026
Cirtran (CIRX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 20, 2026
Cirtran (CIRX) reported revenue of $1.2M for the first quarter 2026 (Q1 2026), +152% from a year earlier and -43% from the quarter before. Operating margin was 3.1%, net earnings $2.2M (191.2% of revenue).
Cirtran, Q1 2026: revenue $1.2M (+152% year over year), operating margin 3.1%, net earnings $2.2M, operating cash flow −$59K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | -43% | +152% |
| Gross profit | $463K | -54% | +71% |
| Operating profit | $36K | -87% | — |
| Net earnings | $2.2M | +409% | — |
| Operating cash flow | −$59K | — | — |
What changed
Revenue was $1.2M in Q1 2026, up 152% year over year and down 43% from the previous quarter. Tobacco Line was the largest line at 97% of revenue. Tobacco Line added $692K year over year (up 162%), 99% of the total change.
Gross margin was 39.9%, down 18.8 points from Q1 2025. Operating profit was $36K, a 3.1% margin (up 12.5 points year over year). Operating expenses grew 36% against revenue growth of 152%. The fastest-growing cost line was SG&A (+61%). Net earnings were $2.2M. The effective tax rate was 0.0%. Non-operating items added $2.2M, 98% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$59K. Non-cash charges added back $0K of depreciation. Working capital and other items used $2.3M.
Questions
What was Cirtran's revenue in the first quarter 2026?
Cirtran (CIRX) reported revenue of $1.2M for the first quarter 2026 (Q1 2026), +152% from a year earlier and -43% from the quarter before.
Was Cirtran profitable in the first quarter 2026?
Operating profit was $36K (3.1% of revenue) and net earnings $2.2M.
Source: Cirtran 10-Q on SEC EDGAR.